PRASAD RAJU (Chief Financial Officer) sold 41.7% of their position (9.87K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $476.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Shares
Shares
+10K
Price / share
—
Trade value
—
% of position
Common Shares
Shares
+6.88K
Price / share
—
Trade value
—
% of position
Common Shares
Shares
−5.85K
Price / share
$48.26
Trade value
$282.22K
% of position
Common Shares
Shares
−4.02K
Price / share
$48.26
Trade value
$194.05K
% of position
Common Shares
Shares
−750.00
Price / share
—
Trade value
—
% of position
Net shares
+6.26K
Net value
-$476.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/14/2026 | M · Option Exercise | +10K | — | — | 147.8% | 6.77K | 16.77K |
| Common Shares Direct | 3/14/2026 | M · Option Exercise | +6.88K | — | — | 41.0% | 16.77K | 23.64K |
| Common Shares Direct | 3/16/2026 | S · Sale | −5.85K | $48.26 | $282.22K | 24.7% | 23.64K | 17.79K |
| Common Shares Direct | 3/16/2026 | S · Sale | −4.02K | $48.26 | $194.05K | 22.6% | 17.79K | 13.77K |
| Common Shares Direct | 3/16/2026 | G · Gift | −750.00 | — | — | 5.4% | 13.77K | 13.02K |
| Total | +6.26K | -$476.28K | ||||||
Restricted Stock Units
Common Shares
10K shares
Shares
−10K
Strike price
Held after
10K
Exercisable
—
Restricted Stock Units
Common Shares
6.88K shares
Shares
−6.88K
Strike price
Held after
20.63K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Shares10K shares | 3/14/2026 | M · Option Exercise | −10K | — | 10K | |
| Restricted Stock Units Direct | Common Shares6.88K shares | 3/14/2026 | M · Option Exercise | −6.88K | — | 20.63K |